Smartphone Use, EMG, and Walking Accelerometry

November 15, 2026 updated by: Ahmed Ali Mohammed Torad, Kafrelsheikh University

Acute Neuromuscular and Accelerometry Responses Across Five Smartphone-Related Walking Conditions in Healthy University Students: A Same-Day Fixed-Sequence Within-Participant Study

This study examines lower-limb muscle activation and smartphone-derived movement characteristics while 100 healthy university students complete five 2-minute walking conditions: forward gaze, downward gaze without a phone, passive smartphone viewing, smartphone texting, and smartphone voice recording. All participants will complete the conditions in the same fixed order, with a 2-minute seated passive-rest interval after each walking bout

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18-30 years. Registered university student. Able to walk independently without an assistive device. Able to look at, type on, and speak into a smartphone while walking. Able to understand study instructions and provide informed consent.

Exclusion Criteria:

  • Lower-limb or neck injury during the preceding 6 months. Diagnosed neurological disorder. Diagnosed vestibular disorder. Uncorrected visual impairment affecting safe walking or smartphone viewing. Inability to type or text comfortably. Any condition identified during screening that made walking while using a smartphone unsafe.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single Group - Five Smartphone Walking Conditions

A single cohort of 100 healthy university students (aged 18-30 years) completing five fixed-sequence 2-minute walking conditions (C1: Forward-gaze walking, C2: Downward-gaze walking without phone, C3: Passive smartphone viewing, C4: Smartphone texting, C5: Smartphone voice recording), with 2 minutes of seated passive rest after each walking bout.

Participants perform five investigator-assigned walking tasks in a fixed order: C1, walking with forward gaze and no smartphone; C2, walking with downward gaze and no smartphone; C3, walking while passively viewing an illuminated smartphone screen; C4, walking while texting on a smartphone; and C5, walking while recording a voice message on a smartphone. Each task lasts 2 minutes, with 2 minutes of seated passive rest after each walking bout. Surface electromyography and pocket-smartphone accelerometry are recorded during each walking condition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Bilateral Tibialis Anterior-Medial Gastrocnemius (TA-MG) Co-Contraction Index
Time Frame: Retained within each 2-minute walking bout across all 5 conditions

Calculated from dynamic surface EMG amplitude recorded at 2000 Hz during steady-state walking across the five conditions.

Retained within each 2-minute walking bout across all 5 conditions
Step Regularity
Time Frame: Retained within each 2-minute walking bout across all 5 conditions

Estimated from the first dominant autocorrelation peak of pocket-smartphone accelerometry.

Retained within each 2-minute walking bout across all 5 conditions

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rectus Femoris-Biceps Femoris (RF-BF) Co-Contraction Index
Time Frame: Retained within each 2-minute walking bout across all 5 conditions

Bilateral knee antagonist co-contraction index calculated from surface EMG.

Retained within each 2-minute walking bout across all 5 conditions

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

January 30, 2027

Study Completion (Estimated)

February 20, 2027

Study Registration Dates

First Submitted

November 14, 2026

First Submitted That Met QC Criteria

November 15, 2026

First Posted (Actual)

November 20, 2026

Study Record Updates

Last Update Posted (Actual)

November 20, 2026

Last Update Submitted That Met QC Criteria

November 15, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Smartphone Walking 2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because the approved ethics and participant-consent provisions do not permit sharing participant-level data outside the study team.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.